Industry Insights
AI's post-deployment ethical blind spots demand accountability now.
Only 9% of FDA-registered AI-based healthcare tools include a post-deployment surveillance plan, leaving most medical AI systems without continuous oversight, according to arxiv .
Omar Haddad·April 26, 2026